50090-1958 : Erythromycin 5 mg/g Ophthalmic Ointment


NDC: 50090-1958
Labeler: A-s Medication Solutions
Product Type: Human Prescription Drug
Drug Name:  Erythromycin
Dosage Form: Ophthalmic Ointment
Application #: ANDA062447
Rev. Date: 


NDC Package Codes:

  • 50090-1958-0: 1 TUBE IN 1 CARTON (50090‑1958‑0) > 3.5 G IN 1 TUBE

Active Ingredients:

  • Erythromycin

Dosage Strength:

  • 5 mg/g

Pharmaceutical Classes:

  • Decreased Sebaceous Gland Activity [PE]
  • Macrolide [EPC]
  • Macrolide Antimicrobial [EPC]
  • Macrolides [CS]

Related Products:

Based on records with the same trade name.
  • 50090-0248 Erythromycin 5 mg/g Ophthalmic Ointment by A-s Medication Solutions
  • 50090-0361 Erythromycin 250 mg Oral Tablet, Film Coated by A-s Medication Solutions
  • 50090-0774 Erythromycin 20 mg/ml Topical Solution by A-s Medication Solutions
  • 50090-1484 Erythromycin 5 mg/g Ophthalmic Ointment by A-s Medication Solutions
  • 50090-1956 Erythromycin 5 mg/g Ophthalmic Ointment by A-s Medication Solutions
  • 50090-4616 Erythromycin 333 mg Oral Tablet, Delayed Release by A-s Medication Solutions
  • 50090-5918 Erythromycin 250 mg Oral Tablet, Film Coated by A-s Medication Solutions
  • 0051-3389 Erythromycin 500 mg Oral Tablet by Abbvie Inc.
  • 0051-6227 Erythromycin 500 mg Oral Tablet, Film Coated by Abbvie Inc.
  • 0051-6290 Erythromycin 333 mg Oral Tablet by Abbvie Inc.
  • 0051-6301 Erythromycin 250 mg Oral Capsule, Delayed Release by Abbvie Inc.
  • 0051-6320 Erythromycin 333 mg Oral Tablet, Delayed Release by Abbvie Inc.
  • 0051-6321 Erythromycin 500 mg Oral Tablet, Delayed Release by Abbvie Inc.
  • 0051-6326 Erythromycin 250 mg Oral Tablet, Film Coated by Abbvie Inc.
  • 0093-5571 Erythromycin 250 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
  • 0093-5572 Erythromycin 500 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
  • 0168-0215 Erythromycin 20 mg/ml Topical Solution by E. Fougera & Co., a Division of Fougera Pharmaceuticals Inc.
  • 0168-0216 Erythromycin 20 mg/g Topical Gel by E. Fougera & Co., a Division of Fougera Pharmaceuticals Inc.
  • 0179-0117 Erythromycin 250 mg Delayed Release Capsule by Kaiser Foundation Hospitals
  • 0378-8212 Erythromycin 20 mg/g Topical Gel by Mylan Pharmaceuticals Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50090-1958 QR Code

< Prev: 50090-1957Next: 50090-1959 >

Related Discussions:

ERYTHROMYCIN DISCUSSIONS
I need to know what this drug is used for? ## sinus infections ## My infant son was perscribed this medicine to help wit... 9 replies
erythromycinbs
my tooth flared out again, the dentist gave me erythromycinbs instead of pulling it. I had some left, so I starting taki... 3 replies
Erythromycin for Sore Throat
I have a severe sore throat and I am feeling nauseous. I was prescribed this medication when I was pregnant because I ca... 3 replies
ERYTHROMYCIN ETHYL 400MG
REASON PRESCRIBED ## Erythromycin is an antibiotic. It's used to treat many kinds of infection. (including pneumonia... 3 replies
Erythromycin 250mg
Hiya im going to be taking erythromycin 250mg and it says on the packet to take 1 tablet 4 times a day spaced between 6 ... 2 replies
Erythromycin via mucose membrane
Please see this as a hypothetical question in regards to having access to just several gastro-resistant pills in an isol... 2 replies
erythromycin es 400mg
what is the es or dr code as in Erythromycin es or Erythromycin dr?? ## i was perscribed erthomycin 400 mg but was does ... 2 replies
Erythromycin and Ciprofloxacin
I just finished taking Ciprofloxacin about two days ago for typhoid. How long should I wait before I can take Erythromyc... 1 reply
erythromycin ophth ointment
I was prescribed this following eyelid surgery. I apply to stitches 3 times per day for 10 days. I developed blisters on... 1 reply
erythromycin. Cellultus infection weakness
Erythromycin 250mg was prescribed to treat cellulitis ,a red itchy rash on my leg , I now know is an infection under the... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.